Prevention and Treatment of Agranulocytosis and Leukopenia in Rats Given Sulfanilylguanidine or Succinyl Sulfathiazole in Purified Diets
- 1 January 1942
- journal article
- research article
- Published by JSTOR in Public Health Reports®
- Vol. 57 (42) , 1559-1566
- https://doi.org/10.2307/4584249
Abstract
Rats given sulfaguanidine (sulfanilylguanidine) or sulfasuxidine (succinyl sulfathiazole) in purified diets develop an agranulocytosis, a leukopenia, and a hypocellularity of bone marrow. This blood dyscrasia can largely be prevented or successfully treated with whole dried liver or with certain liver extracts.This publication has 7 references indexed in Scilit:
- Biotin Deficiency and Other Changes in Rats Given Sulfanilylguanidine or Succinyl Sulfathiazole in Purified DietsScience, 1942
- The Occurrence of Hyaline Sclerosis and Calcification of Blood Vessels in Rats on SulfaguanidinePublic Health Reports®, 1942
- NUTRITIONAL CYTOPENIA IN MONKEYS RECEIVING THE GOLDBERGER DIETThe Journal of Experimental Medicine, 1940
- NUTRITIONAL CYTOPENIA (VITAMIN M DEFICIENCY) IN THE MONKEYThe Journal of Experimental Medicine, 1938
- PANMYELOPHTHISIS WITH HEMORRHAGIC MANIFESTATIONS IN RATS ON A NUTRITIONAL BASISThe Journal of Experimental Medicine, 1937
- Leukopenia and Anemia in the Monkey Resulting from Vitamin DeficiencyJournal of Nutrition, 1935
- THE PRODUCTION IN DOGS OF CHRONIC BLACK TONGUE WITH ANEMIAThe Journal of Experimental Medicine, 1933